Ardent Health, Inc. (ARDT)
| Market Cap | 1.53B-25.6% |
| Revenue (ttm) | 6.41B |
| Net Income | 78.23M |
| EPS | 0.54 |
| Shares Out | 141.05M |
| PE Ratio | 20.15 |
| Forward PE | 8.67 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 684,128 |
| Open | 10.55 |
| Previous Close | 10.68 |
| Day's Range | 10.62 - 10.95 |
| 52-Week Range | 7.71 - 15.48 |
| Beta | 0.72 |
| Analysts | Buy |
| Price Target | 12.67(+16.42%) |
| Earnings Date | Nov 11, 2026 |
Insiders here have filed 3 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About ARDT
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$ARDT stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in ARDT holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ARDT's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ARDT Estimated quarterly lobbying spending
Source: U.S. Senate LDA
ARDT Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Net patient service revenue | $1.60B | 98.37% |
| Other revenue | $26.48M | 1.63% |
| Percentage of revenue | $1.00K | 0.00% |
| Other revenue, percentage of revenue | $16 | 0.00% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New ARDT patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ARDT from public contracts
Source: USAspending.gov
ARDT Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ARDT’s recent data — informational, not investment advice